Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
JNJ-0631
i
Other names:
JNJ-0631, ARX305, anti-CD70 ADC, NCB002, ARX 305, ARX-305, JNJ0631, JNJ 0631, NCB-002, NCB 002
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(1)
News
Trials
Company:
J&J, Zhejiang Medicine
Drug class:
Tubulin inhibitor, CD70-targeted antibody-drug conjugate
Related drugs:
‹
paclitaxel (178)
albumin-bound paclitaxel (67)
trastuzumab botidotin (6)
JNJ-95298177 (3)
micellar paclitaxel (3)
REGN5093-M114 (3)
XMT-1660 (3)
vinblastine (3)
HZX-02-059 (2)
AR160 (2)
DJ 927 (2)
ACT-903 (1)
ADC2122 (1)
paclitaxel oral (1)
oral paclitaxel/encequidar (1)
YH012 (1)
hIMB1636-MMAE (1)
ABT-751 (0)
BMS-986148 (0)
CBP-1018 (0)
paclitaxel polymeric micelle formulation (0)
paclitaxel liposomal (0)
liposomal paclitaxel (0)
paclitaxel nanoformulation (0)
paclitaxel-hyaluronic acid conjugate (0)
paclitaxel poliglumex (0)
FID-007 (0)
CB 3304 (0)
BAY 59-8862 (0)
ANG1005 (0)
SGN-CD70A (1)
AMG 172 (0)
GEN1160 (0)
MDX-1203 (0)
paclitaxel (178)
albumin-bound paclitaxel (67)
trastuzumab botidotin (6)
JNJ-95298177 (3)
micellar paclitaxel (3)
REGN5093-M114 (3)
XMT-1660 (3)
vinblastine (3)
HZX-02-059 (2)
AR160 (2)
DJ 927 (2)
ACT-903 (1)
ADC2122 (1)
paclitaxel oral (1)
oral paclitaxel/encequidar (1)
YH012 (1)
hIMB1636-MMAE (1)
ABT-751 (0)
BMS-986148 (0)
CBP-1018 (0)
paclitaxel polymeric micelle formulation (0)
paclitaxel liposomal (0)
liposomal paclitaxel (0)
paclitaxel nanoformulation (0)
paclitaxel-hyaluronic acid conjugate (0)
paclitaxel poliglumex (0)
FID-007 (0)
CB 3304 (0)
BAY 59-8862 (0)
ANG1005 (0)
SGN-CD70A (1)
AMG 172 (0)
GEN1160 (0)
MDX-1203 (0)
›
Associations
(1)
News
Trials
VERI cancer hierarchy
Reset Filters
CD70 expression
Uterine Leiomyosarcoma
CD70 expression
Uterine Leiomyosarcoma
JNJ-0631
Sensitive: C3 – Early Trials
JNJ-0631
Sensitive
:
C3
JNJ-0631
Sensitive: C3 – Early Trials
JNJ-0631
Sensitive
:
C3
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login